Neochem Bio IPO
LiveAlready have an account? Apply now
Neochem Bio IPO details
Schedule of Neochem Bio
| Issue open date | 02 Dec 2025 |
| Issue close date | 04 Dec 2025 |
| UPI mandate deadline | 04 Dec 2025 (5 PM) |
| Allotment finalization | 05 Dec 2025 |
| Refund initiation | 08 Dec 2025 |
| Share credit | 08 Dec 2025 |
| Listing date | 09 Dec 2025 |
| Mandate end date | 19 Dec 2025 |
| Lock-in end date for anchor investors (50%) | 04 Jan 2026 |
| Lock-in end date for anchor investors (remaining) | 05 Mar 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Neochem Bio
Neochem Bio Solutions Limited is a specialty performance chemical manufacturer with a legacy of over four decades. The company traces its roots to 1978 and was incorporated as a private limited entity in 2017. It is promoted by Swapnil Rameshbhai Makati and Hemangini Swapnil Dathia.
Neochem develops over 350 customized formulations across polymers, surfactants, silicones, esters, and bio-based solutions. Its products serve diverse industries, including textiles, home and personal care, institutional cleaning, water treatment, paints and coatings, paper and pulp, construction, rubber, and dyes and pigments. The company operates on a formulation-driven business model focused on application-specific solutions. It offers certified products backed by ISO 9001:2015, ISO 14001, ISO 45001, ZDHC Level 3, and GOTS 7.0 accreditations. Strong technical capabilities, a diversified product range, and long-standing industry experience form the company’s key strengths.
Financials of Neochem Bio
Issue size
| Funds Raised in the IPO | Amount |
| Total issue size | 44.97 |
| Fresh Issue – Proceeds go to the company | 44.97 |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Funding the long-term working capital requirements of the Company | 23.9 (53.13%) |
| Repayment/prepayment of borrowings | 10 (22.24%) |
| General corporate purpose | 11.07 (24.63%) |
Strengths
- Diversified portfolio of 350+ speciality chemical formulations across multiple end-use industries.
- Strong industry presence backed by four decades of technical and formulation expertise.
- Accredited with ISO 9001:2015, ISO 14001, ISO 45001 and product certifications like ZDHC Level 3 & GOTS 7.0.
- Serving wide applications including textile, HPC, water treatment, coatings, paper, construction, rubber, and dyes.
- Strong revenue and profitability growth with improving margins and high ROCE performance.
Risks
- Significant dependence on top customers, with the top 5 customers contributing a major share of revenues.
- Exposure to credit risk due to reliance on customer receivables.
- Inability to attract or retain key managerial and technical employees may impact operations.
- Trademark protection risks due to pending registrations and potential third-party infringements.
- Dependence on bank credit facilities for working capital may affect liquidity and operations if disrupted.
Allotment Status for Neochem Bio
To check your IPO allotment status:
- Visit the MUFG Intime India IPO Application Status page.
- Select the company name from the dropdown menu.
- Select and enter one of the following: PAN, Application Number, DP/Client ID, or Account Number/IFSC.
- Click Submit to view your allotment status.
Subscription Figures for Neochem Bio
As per media reports (Link), the Grey Market Premium (GMP) of Neochem Bio is reported at ₹6 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on December 03, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| Institutional | 8.71 | 10.74 | 1.23x |
| NII | 6.55 | 13.13 | 2x |
| Retail | 15.26 | 15.31 | 1x |
| Total | 30.53 | 39.18 | 1.28x |